These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10605356)

  • 1. Medicare's Cooperative Cardiovascular Project: can we trust our MetaStar report cards? Cardiovascular Care Committee of Wausau Hospital.
    Murdock DK; Engelmeier RS; Logemann T; Schlund A; Haehlke R
    WMJ; 1999; 98(6):44-8; discussion 49. PubMed ID: 10605356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing quality of care for acute myocardial infarction: shifting the focus of improvement from key indicators to process of care and tool use: the American College of Cardiology Acute Myocardial Infarction Guidelines Applied in Practice Project in Michigan: Flint and Saginaw Expansion.
    Mehta RH; Montoye CK; Faul J; Nagle DJ; Kure J; Raj E; Fattal P; Sharrif S; Amlani M; Changezi HU; Skorcz S; Bailey N; Bourque T; LaTarte M; McLean D; Savoy S; Werner P; Baker PL; DeFranco A; Eagle KA;
    J Am Coll Cardiol; 2004 Jun; 43(12):2166-73. PubMed ID: 15193675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of ACE inhibitors in the treatment of heart failure in Kentucky Medicare beneficiaries: a quality improvement project.
    Boer HR; Pritchard C; Okpokho NA; Lewis JN
    J Ky Med Assoc; 2002 Aug; 100(8):317-22. PubMed ID: 12222104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MetaStar: Wisconsin's quality improvement organization.
    Gold JA; Simmons K
    WMJ; 2006 Dec; 105(8):38-9. PubMed ID: 17256707
    [No Abstract]   [Full Text] [Related]  

  • 7. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study.
    Ueshima K; Fukami K; Hiramori K; Hosoda S; Kishida H; Kato K; Fujita T; Tsutani K; Sakuma A;
    Am Heart J; 2004 Aug; 148(2):e8. PubMed ID: 15309011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National and state trends in quality of care for acute myocardial infarction between 1994-1995 and 1998-1999: the medicare health care quality improvement program.
    Burwen DR; Galusha DH; Lewis JM; Bedinger MR; Radford MJ; Krumholz HM; Foody JM
    Arch Intern Med; 2003 Jun; 163(12):1430-9. PubMed ID: 12824092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital therapy traditions influence long-term survival in patients with acute myocardial infarction.
    Stenestrand U; Lindbäck J; Wallentin L
    Am Heart J; 2005 Jan; 149(1):82-90. PubMed ID: 15660038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.
    Suşan M; Petrescu L; Riviş AI; Suşan RM; Burghină D; Dan R; Cozma D; Drăgulescu SI
    Rom J Intern Med; 2005; 43(3-4):187-98. PubMed ID: 16812979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in acute myocardial infarction in 4 US states between 1992 and 2001: clinical characteristics, quality of care, and outcomes.
    Masoudi FA; Foody JM; Havranek EP; Wang Y; Radford MJ; Allman RM; Gold J; Wiblin RT; Krumholz HM
    Circulation; 2006 Dec; 114(25):2806-14. PubMed ID: 17145994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCORT/CCS quality indicators for acute myocardial infarction care.
    Tran CT; Lee DS; Flintoft VF; Higginson L; Grant FC; Tu JV; Cox J; Holder D; Jackevicius C; Pilote L; Tanser P; Thompson C; Tsoi E; Warnica W; Wielgosz A; ;
    Can J Cardiol; 2003 Jan; 19(1):38-45. PubMed ID: 12571693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in treatment of heart failure and acute myocardial infarction: a question of quality or epidemiology?
    Gold LD; Krumholz HM
    Cardiol Rev; 2006; 14(4):180-6. PubMed ID: 16788330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: analysis of the cooperative cardiovascular project.
    Berger AK; Radford MJ; Krumholz HM
    Am Heart J; 2000 Jun; 139(6):985-92. PubMed ID: 10827378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure in primary care: measuring the quality of care.
    James PA; Cowan TM; Graham RP; Jaén CR; Majeroni BA; Schwartz JS
    J Fam Pract; 1999 Oct; 48(10):790-8. PubMed ID: 12224677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
    Tokmakova M; Solomon SD
    Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost analysis of community screening for diabetes in the central Wisconsin Medicare population (results from the MetaStar pilot project in Wausau).
    Lee DS; Remington P; Madagame J; Blustein J
    WMJ; 2000 Jun; 99(3):39-43. PubMed ID: 10927980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of age on the use of evidence-based therapies for acute myocardial infarction.
    Tran CT; Laupacis A; Mamdani MM; Tu JV
    Am Heart J; 2004 Nov; 148(5):834-41. PubMed ID: 15523314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of valsartan for the treatment of heart-failure patients not receiving ACE inhibitors: a budget impact analysis.
    Smith DG; Cerulli A; Frech FH
    Clin Ther; 2005 Jun; 27(6):951-9. PubMed ID: 16117995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.